In a genetic mouse PD model (MitoPark), the delivery of the GDNF gene to the SN using this system resulted in a 3.2-fold increase in the recovery of TH+ neurons and a 3.9-fold improvement in motor function relative to untreated PD mice. The gene discussed is GDNF; the disease is Parkinson disease.